OTCM
HPTN
Market cap22kUSD
Dec 03, Last price
0.00USD
Name
Happy Town Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating through its various subsidiaries, Red Eye Guys Ltd. specializes in creating and manufacturing the Biologix Hair Therapy System. This innovative system includes both a specialized formulation and an administration method to combat Follicle Nutrient Deficiency Syndrome (FNDS). A key element of this system is Biologix Revive, a particular hair formula that is delivered directly to FNDS-compromised follicles via a series of precise, shallow needle injections. The company's therapeutic solution is engineered to address, reverse the effects of, and prevent the onset of FNDS, as well as to treat alopecia areata. Known as Biologix Hair, Inc. until April 2014, the firm subsequently changed its name to Red Eye Guys Ltd. The company is headquartered in Toronto, Canada, and maintains subsidiary operations in Barbados and Panama.
Key people
Mark Maybank
Non-Executive Independent Chairman of the Board · since 2013
Donna Lieder
Vice President - Clinician Licensing · since 2013
Janice Matthews
Vice President - Corporate Communications · since 2013
Lilia Roberts
Treasurer, Secretary · since 2013
Ronald Holland
Director · since 2013
Director · since 2013
Chief Executive Officer, Director · since 2013
J. Gregory Wilson
Chief Financial Officer, Director · since 2013
David Csumrik
Non-Executive Independent Director · since 2013
William Keller
Non-Executive Independent Director · since 2013
Ken Zadoorian
Non-Executive Independent Director · since 2013
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||
Revenues | |||
Cost of revenue | |||
Unusual Expense (Income) | |||
NOPBT | |||
NOPBT Margin | |||
Operating Taxes | |||
Tax Rate | |||
NOPAT | |||
Net income | |||
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | |||
BB yield | |||
| Debt | |||
Debt current | |||
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | |||
| Cash flow | |||
Cash from operating activities | |||
CAPEX | |||
Cash from investing activities | |||
Cash from financing activities | |||
FCF | |||
| Balance | |||
Cash | |||
Long term investments | |||
Excess cash | |||
Stockholders' equity | |||
Invested Capital | |||
ROIC | |||
ROCE | |||
| EV | |||
Common stock shares outstanding | |||
Price | |||
Market cap | |||
EV | |||
EBITDA | |||
EV/EBITDA | |||
Interest | |||
Interest/NOPBT | |||